Acupuncture and Microglial Modulation

Why Does Pain Persist in Juvenile Idiopathic Arthritis Even After Inflammation Is Controlled?

Juvenile idiopathic arthritis is the most common form of chronic arthritis in children, encompassing several subtypes that share inflammation of one or more joints lasting at least six weeks before the age of 16. While modern disease-modifying antirheumatic drugs and biologics have dramatically improved control of joint inflammation, a significant proportion of children continue to report chronic pain even when objective markers of disease activity have improved or resolved. This disconnect between inflammation control and pain experience has pushed researchers to look beyond the joint itself.

A growing body of evidence suggests that prolonged peripheral inflammatory signaling can drive lasting changes in the central nervous system, a process known as central sensitization. In this state, neurons in the spinal cord and brain become hyperexcitable, amplifying pain signals and sometimes generating pain in response to normally non-painful stimuli. Microglia — the resident immune cells of the central nervous system — appear to play a central role, releasing pro-inflammatory cytokines and reshaping synaptic signaling in ways that perpetuate chronic pain even after the initial inflammatory trigger fades.

How Might Acupuncture Influence the Neuro-Immune Axis in Chronic Pain?

The recent Frontiers review synthesizes preclinical and translational evidence suggesting that acupuncture, particularly electroacupuncture, can influence microglial activity and downstream neuro-immune signaling. In animal models of inflammatory and neuropathic pain, acupuncture has been associated with reduced activation of microglial markers and lower levels of pro-inflammatory cytokines in the dorsal horn of the spinal cord. These effects are thought to involve pathways linked to purinergic receptors, toll-like receptors, and several intracellular signaling cascades.

While these mechanistic insights are intriguing, the authors emphasize that clinical evidence specifically in pediatric JIA populations remains limited. Most existing acupuncture trials have focused on adult chronic pain conditions, and applying findings to children requires caution given developmental differences in pain processing and immune function. Still, the review positions acupuncture as a potentially worthwhile adjunctive avenue to explore alongside standard pharmacological care, particularly for young patients whose pain persists despite optimized medication regimens.

What Does This Mean for Families and Clinicians Today?

For families navigating chronic pain in a child with JIA, the take-home message is one of cautious optimism. Disease-modifying antirheumatic drugs, biologics targeting cytokines such as TNF and IL-6, and structured physical therapy remain the evidence-based foundations of care. Any complementary approach, including acupuncture, should be discussed with the treating pediatric rheumatologist and integrated into a broader pain management plan rather than used as a substitute for proven therapies.

Looking forward, researchers are calling for well-designed randomized controlled trials specifically in pediatric populations to clarify whether acupuncture meaningfully reduces pain, improves function, and influences biomarkers of central sensitization in JIA. If the neuro-immune mechanisms outlined in the Frontiers review hold up in clinical studies, acupuncture and other neuromodulatory strategies could become part of a more comprehensive, mechanism-informed approach to pediatric chronic pain.